Introduction: Myocardial inflammation often coexists with different types of autoimmune diseases. Our aim was to investigate the presence of myocarditis in these patients by Cardiovascular Magnetic Resonance (CMR) and endomyocardial biopsy.
INTRODUCTION
Myocarditis is the inflammation of the heart due to infectious, toxic, or autoimmune processes. The clinical presentation of the disease ranges from non-specific systemic symptoms (fever, myalgias, palpitations, or exertional dyspnea) to fulminant hemodynamic collapse and sudden death [1] . It can also mimic acute myocardial infarction, with sudden onset of chest pain, ECG abnormalities, troponin elevation, arrhythmias, or hemodynamic instability [2] . The diagnosis of myocarditis is still a challenge because of the nonspecific pattern of clinical presentation and the lack of standardized diagnostic process. Additionally, myocardial inflammation is one of the major complications in the management of patients with autoimmune diseases. The severity of cardiac involvement in these patients has been recognized since the beginning of 20th century. However, only recently a detailed evaluation of cardiac lesions became *Address correspondence to this author at the Onassis Cardiac Surgery Center, 50 Esperou Street, 175-61 P.Faliro, Athens, Greece; Tel/Fax: +30-210-98.82.797; E-mail: soma13@otenet.gr feasible, due to the introduction of very sensitive, non-invasive cardiac imaging techniques [3] [4] [5] .
The pathogenesis of myocarditis is characterized by an initial inflammatory process and a final myocardial remodelling and fibrosis, which is particularly amenable to imaging by cardiovascular magnetic resonance. CMR is a promising tool for diagnosing myocarditis after showing that contrast enhancement evolves from a focal to a disseminated process during the first weeks after the onset of symptoms [6] . New contrast CMR techniques using segmented inversion recovery gradient-echo pulse sequences (IR-GRE) have also been successfully used in both viral and autoimmune diseases [4, 7] . However, these findings need further validation in autoimmune diseases and comparison with histology and PCR evaluation of myocardial specimens [8] .
PATIENTS AND METHODS

Patient Population
Twenty patients, aged 20-55 years, with autoimmune diseases were studied. They were referred to our tertiary center for evaluation of cardiac symptoms and carried a diagnosis of Takayasu's arteritis (three), systemic lupus erythematosus (three), rheumatoid arthritis (five), autoimmune thyroid disease (seven) and systemic sclerosis (two). All patients were under adequate treatment for the systemic disease, which was considered under remission. Additionally, patients received ACE-inhibitors and statins treatment. Clinical data of the patients included are given in Table 1 . Eighteen of them had a history of autoimmune disease for at least 2 years and only in two the diagnosis of autoimmune disease was established the last 5 months. Their main cardiac symptoms were: shortness of breath, chest pain and/or palpitations. In four patients, with a recent onset of autoimmune disease, a slight increase of myocardial troponin I (2.5-3.5 ng/ml) was found (normal values: <0.4 ng/ml). Further more, three patients had a history of increased troponin two months before the CMR evaluation and another two had recurrent episodes of chest pain, but without an increase in troponin I. Finally, three patients had a history of recently reduced left ventricular ejection fraction. Patients CMR data were compared with those of twenty patients with the same autoimmune diseases but without cardiac symptoms, who served as controls. This control group was selected on a sequential basis from the outpatient clinic at the time of their annual evaluation. All patients and controls gave written consent form and the study was approved by the hospital's ethics committee.
Methods
The presence of myocarditis and the left ventricular systolic function were evaluated by CMR. Myocarditis was documented using T2-weighted (T2-W), T1-weighted (T1-W) before and after contrast media injection and late enhanced images (LGE). The study was considered as positive, if 2 out 3 imaging sequences gave positive results.
A. CMR Evaluation of Inflammation
Cardiovascular magnetic resonance examination was performed in a 1.5 T Philips Intera system using STIR T2-weighted (T2-W), T1-weighted (T1-W) before and after contrast media injection and late enhanced images (LGE). ECG-triggered, STIR T2-W multislice spin-echo sequence was performed in axial orientation and the signal ratio measured from the region of interest covering the myocardium of the left ventricle as well as within a skeletal muscle in the same slice. ECG-triggered T1-W multislice spin-echo images were also obtained in axial orientation with identical parameters before and after an intravenous bolus of 0.1mmol/kg Gd-DTPA. Measurements after Gd-DTPA were started within 1 minute of injection (early T1) in the same area as in T2-W. Immediately after the second set of T1-W images, 0.1 mmol/kg Gd-DTPA was given again and epicardial late gadolinium-enhanced images (LGE) were taken 15 min later, using an a 3D-T1-TFE sequence, preconditioned with a 180 degrees inversion pulse (flip angle =15°, TE=1.4 msec, TR=5.5 ms, TI 225 to 275 ms as individually optimized to null myocardial signal, matrix 256X192 and slice thickness=5 mm). Images were analyzed according to previously described protocols [6] .
B. CMR Functional Study
For each subject, localizing scans were obtained to define the long (2-chamber) axis of the left ventricle. A mid ventricular short axis view was then prescribed, and used to plan a 4-chamber view. The short axis orientation was then defined accurately, perpendicular to both the 2-and 4-chamber views. To cover the entire left ventricle, 10 contiguous (gap=0 mm) short axis slices were acquired in each study. The imaging sequence was a 2D, multi-phase (16 cardiac phases were acquired per cardiac cycle resulting to a temporal resolution of 47 ms for a heart rate of 80 beats/min), steady-state free-precession (SSFP) sequence (TE=1.5 ms, TR=3.1 ms, flip angle=70°, slice thickness=8 mm, acquired in-plane spatial resolution=1.8 mm x 2.0 mm) characterized by the application of balanced gradients in all directions.
C. Endomyocardial Biopsy (EMB)
In 10 patients with CMR positive for myocarditis and either reduced left ventricular ejection fraction (LVEF) or recent increase in troponin, endomyocardial biopsy was also performed according to guidelines about myocardial biopsy [9] . Biopsy specimens were evaluated both by histological and polymerase reaction techniques (PCR). Eight endomyocardial specimens (EMBs) were obtained from the right side of the ventricular septum of each patient with clinical suspicion of myocarditis, using a flexible bioptome (Westmed, Germany) via the femoral vein approach. Four specimens were used for the histologic evaluation, whereas the remaining 4 specimens were subjected to DNA and RNA extraction, using commercially prepared protocols (see below), to detect viral or microbial genomes.
D. Histopathologic Analysis
EMBs were stained with Masson's trichrome as well as Giemsa stain and examined by light microscopy [10] . For immunohistological identification of cardiac immune cells, tissue sections were treated with an avidin-biotinimmunoperoxidase method according to the manufacturer's protocol (Vectastain Elite ABC Kit, Vector), applying the following monoclonal antibodies: CD3 (T cells, Novocastra Laboratories) and PGM1 (macrophages, Dako).
The detection of >14 infiltrating leukocytes/mm 2 in the presence of myocyte damage and/or fibrosis in addition to enhanced HLA class II expression in professional antigenpresenting immune cells and endothelium was used for the diagnosis of active myocarditis. Healing myocarditis was considered if the inflammation was less extensive (<14 leukocytes/mm 2 ), whereas healed myocarditis was characterized by multifocal fibrosis or scarring without inflammation (0 to 3 leukocytes/mm 2 , which is identical to normal myocardium [11] .
Detection of Viral Genomes DNA and RNA was extracted simultaneously from frozen heart muscle tissue probes. Polymerase chain reaction (PCR)/reverse transcriptase (RT)-PCR was performed for the detection of EVs (including Coxsackieviruses and Echoviruses), ADVs, Parvovirus B19 (PVB19), Human Cytomegalovirus, Epstein-Barr-virus, Herpes virus 1-6, Chlamydia pneumoniae and trachomatis as described. The quality (purity) and quantity of the extracted nucleic acids (DNA, RNA) was evaluated on a Nanodrop 2000c spectrophotometer (ThermoScientific). As a control for the successful extraction of RNAs, as well as for the presence of PCR inhibitors a Reverse Transcription Real Time PCR assay was designed with primer/probe sequences from the G-6PDH (glucose-6-phosphate dehydrogenase) or b2-microglobulin or human acidic ribosomal protein cDNAs (data not shown). For the verification of the DNA extraction a conventional PCR assay was designed with specific primers for the human b-globin gene (IVS-2, data not shown).
DNA Extraction: DNA was extracted with the use of the DNeasy tissue Kit (QIAGEN, BioAnalytica, Athens, Greece) according to the manufacturer's instructions and was stored at -20 o C for further processing.
RNA Extraction: Total RNA was extracted with the use of RNeasy Mini Kit (QIAGEN, BioAnalytica, Athens, Greece) according to the manufacturer's instructions. Total RNA was collected in 40 μl of RNase free water.
Conventional PCR -Adenoviruses (ADVs) DNA was detected using the previously published technique [12] , and the results of the amplification reaction were separated by electrophoresis, stained with ethidium bromide and visualized and photographed with UV transillumination. The sensitivity of the technique is 500 IFU/mL and the specificity is approximately 96%.
Cytomegalovirus (CMV) DNA was detected using nested PCR protocol previously described [13] , and the results of the amplification reaction were separated by electrophoresis, stained with ethidium bromide and visualized and photographed with UV transillumination. The sensitivity of the technique is 500 copies/mL and the specificity is approximately 95%.
RealTime PCR -HSV1/2 DNA was detected using the previously published technique [14] , utilizing the FRET (fluorescence resonance energy transfer) principle, following by melting curve analysis for genotype (I or II) discrimination, according to the authors' suggestions. The sensitivity of the technique is 100 copies/cell and the specificity is approximately 95%.
-VZV DNA was detected using the previously published technique [15] utilizing the FRET (fluorescence resonance energy transfer) principle, according to the authors' suggestions. The sensitivity of the technique is 1000 copies/mL and the specificity is approximately 97%.
-EBV DNA was detected using the previously published technique [16] , utilizing the FRET (fluorescence resonance energy transfer) principle, according to the authors' suggestions. The sensitivity of the technique is 1000 copies/mL and the specificity is approximately 97%.
-HHV-6 DNA was detected using the previously published technique [17] , utilizing the FRET (fluorescence resonance energy transfer) principle, according to the authors' suggestions. The sensitivity of the technique is 100 copies/cell and the specificity is approximately 95%.
Parvovirus B-19 DNA was detected using the previously published technique [18] , utilizing the FRET (fluorescence resonance energy transfer) principle, according to the authors' suggestions. The sensitivity of the technique is 100 copies/cell and the specificity is approximately 97%.
Chlamydia pneumoniae DNA was detected using the previously published technique [19] , utilizing the FRET (fluorescence resonance energy transfer) principle, according to the authors' suggestions. The sensitivity of the technique is 100 CFU/sample and the specificity is approximately 97%.
Chlamydia trachomatis DNA was detected using the previously published technique [20] , utilizing the SYBR Green Technology following by melting curve analysis according to the authors' suggestions. The sensitivity of the technique is 100 IFU/mL and the specificity is approximately 97%.
Enterovirus RNA was detected using an RT-PCR Quantitative in vitro Diagnostics kit (ARTUS GmbH, GERMANY). The sensitivity of the technique is 10 copies/mL and the specificity is approximately 97%.
During the initial application of the experiment the specificity of the assay was ensured by checking the primers/probes sequences for possible homologies to all in the gene banks published sequences by sequence comparison analysis.
E. Statistical Analysis
Continuous data were expressed as mean±SD. Statistical analysis was performed using Mann-Whitney U-test. A pvalue of < 0.05 was considered for statistical significance.
RESULTS
Myocardial inflammation was identified in 18/20 patients examined by CMR. In the T2-W images the signal ratio of myocardium to skeletal muscle was 1.89±0. 25 (control values 1.57±0.13, p<0.05), indicative of oedema. From the T1-W images, the early T1-W ratio was 11.31±11.18 (control values 3.09±0.05, p<0.05), due to myocardial inflammation. Epicardial late gadolinium enhanced areas (LGE) were identified in all 18 patients. In 8/18 the LGEs were located in the posterior, or posterolateral wall (Fig. 1) , in 5/18 in the intraventricular septum and in 5/18 in both the posterior, or posterolateral wall and the intraventricular septum. The left ventricular end-diastolic volume (LVEDV), end-systolic volume (LVESV) and ejection fraction (LVEF) were 123.25±34.01 ml, 50.11±30.24 ml and 60.8±13.22%, respectively. Only in 3/18 patients (16.67%) with CMR evidence of myocarditis the LVEF was < 45%. From these patients, the first had a recent history of Takayasu disease, the second a recent history of Graves disease and the third a 2-year history of systemic sclerosis ( Table 2) .
At endomyocardial biopsy performed in 10/20 patients with the most striking clinical features and positive CMR, histology revealed the presence of myocarditis in 5/10 (50%) (active myocarditis in 2 and healing myocarditis in 3). PCR evaluation of specimens documented the presence of viral or microbial genomes in 8/10 (80%). Histologically proved myocarditis and positive PCR were in agreement with 50% and 80% of positive CMR examinations, respectively. A patient with both positive CMR and histology is presented in Fig. (1) . Herpes virus was identified in 3/10, Adenovirus in 1/10, Coxsackie B6 in 1/10, Echo virus in 1/10, Parvo-B19 in 3/10, CMV in 1/10 and Chlamydia trachomatis in 8/10. More than one viruses or combination of viruses with Chlamydia trachomatis were identified in 6/10 (60%). Detailed PCR findings are presented in Table 3 . In 2/10 patients with a history of rheumatoid arthritis and positive CMR, both histology and PCR evaluation was negative (Fig.  2) . Fig. (1) . Area of late gadolinium enhancement (LGE) in the intraventricular septum of a patient with Graves disease (arrow, above) and positive histology of myocardial specimens (arrows, below).
DISCUSSION
In this study we investigated the presence of myocarditis in a population of patients with different types of autoimmune disease and cardiac symptoms, who were under adequate treatment and the systemic disease was considered under remission. CMR documented the presence of myocarditis in the majority of patients, although the clinical findings were not clearly suggestive of myocardial inflammation in all of them. Histologic evaluation of myocardial specimens verified the presence of inflammation in half of CMR positive patients and myocardial PCR of the same patients revealed the presence of viral or microbial genomes in the majority of them. Only few data are available about the presence of myocarditis in autoimmune diseases [21] [22] [23] and most of them refer to systemic lupus erythematosus (SLE) (4, 5) . Our group has recently assessed the presence of inflammation in different types of vasculitis [24] [25] [26] . According to our knowledge, there are no available data about CMR evaluation and myocardial biopsy in a broad spectrum of autoimmune diseases. The exact mechanism of myocardial inflammation in autoimmune diseases is rather obscure and varies according to the pathophysiology of the underlying disease.
In SLE, the disease most likely represents immune complex mediated vascular phenomenon resulting in interstitial inflammation and secondary myocyte injury [4] . Circulating antibodies such as antimyocardial or anticardiolipin antibodies may also contribute to lupus myocarditis [4] .
In cases of scleroderma the presence of myocarditis has been also well documented. In a retrospective review of 47 patients with progressive systemic sclerosis a highly significant association between myositis and myocarditis was documented. Despite an excellent clinical response to steroids, the late occurrence of life-threatening conduction system defects appeared while they were receiving therapy. Consequently, patients with progressive systemic sclerosis should be evaluated for a coexisting myocarditis [21, 22] .
In autoimmune thyroid diseases, the classic high-output thyrotoxic heart disease is generally considered as a direct effect of thyroid hormone. In contrast, the cause of the less common low-output heart failure is generally unknown. In a study group consisted of 11 patients whose mean age was 47 years, when they were diagnosed with hyperthyroidism and 52 years when diagnosed with cardiac dysfunction, the right ventricular endomyocardial biopsy tissue revealed severe lymphocytic myocarditis in a patient with severe ophthalmopathy and showed borderline myocarditis in a patient without ophthalmopathy. Biopsy tissues from 6 other patients showed appreciable myocyte hypertrophy and interstitial fibrosis, consistent with dilated cardiomyopathy. Thus, among patients with Graves' disease, most cases of low-output cardiac dysfunction appear to be due to causes other than an active autoimmune inflammatory process [23] .
In rheumatoid arthritis the presence of myocarditis due to vasculitis has been also documented in a 49-year-old man with rheumatoid arthritis who presented with acute congestive heart failure. Biopsy of the right ventricle revealed heavy endothelial deposits of IgM in the small blood vessels of the myocardium. Prednisone therapy resulted in resolution of the symptoms of congestive heart failure. This is the first report documenting rheumatoid arteritis antemortem by endomyocardial biopsy [27] . Additionally, 3 children with myocarditis as part of juvenile rheumatoid arthritis (JRA) were described. The diagnosis was established by the appearance of cardiomegaly or congestive heart failure or both in the absence of substantial pericardial effusion or extra cardiac cause. Myocarditis, in these cases, occurred on a background of severe, active systemic disease. Although no pathologic specimens from hearts of acute cases were available, an autopsy specimen of one child who died after two months of treatment with high doses of steroids, showed diffuse changes typical of the "dilated ventricle" type of cardiomyopathy. Treatment with high doses of corticosteroids has been rapidly successful in controlling the acute phase [28] .
In Takayasu disease the coexistence of myocarditis with the subclavian stenosis has been already described. According to previous studies, myocarditis appeared to occur commonly in nonspecific aortoarteritis during the acute phase of the disease and precipitated congestive cardiac failure in some patients. Immunosuppressive therapy showed promise and needs further evaluation [29] [30] [31] .
In our population, the CMR parameters of myocardial inflammation did not correlate with a clinically overt myocardial involvement or with left ventricular dysfunction in all of the patients and were independent of treatment for the systemic disease. This is in agreement with other studies and reflects the possibility of subclinical myocardial involvement in autoimmune diseases [4, 21, 22] .
The positive PCR of myocardial specimens in the majority of our patients emphasizes the role of viral and microbial genomes in the pathophysiology of myocarditis in autoimmune patients. Concerning Chlamydia, the most frequent finding, although the heart is not their primary target, once they are carried to the host's heart they promote inflammation [32] . Myocarditis occurs when the host fails to control the infection. Under these circumstances, the real prevalence of Chlamydia-induced myocarditis may be higher than previously documented [33] . Infection with Chlamydia trachomatis leads to production of autoantibodies to heart muscle-specific epitopes and Chlamydia-mediated heart disease is induced [34] . Since Chlamydia can be treated with antibiotics, the possible etiologic association with myocarditis could have important therapeutic implications [35] . Additionally, it is not surprising that in two of our patients with rheumatoid arthritis no viral genomes were detected. Rheumatic vasculitis is the main cause of inflammation in these patients [27] and usually it responses to steroids and azathioprime.
CMR can easily visualize the entire myocardium and it is ideal for a patchy process like myocarditis. It is also very sensitive to tissue composition changes, which take place during myocarditis. The imaging protocol used in this study, captures the three basic phenomena of the myocardial inflammatory response (edema, increased capillary leakage and focal necrosis/fibrosis) and may offer a potential noninvasive diagnostic tool in these patients. A combined CMR approach using T2-W, early and late gadolinium enhancement has a sensitivity of 76%, a specificity of 95.5% and a diagnostic accuracy of 85% in the detection of viral myocarditis [6] . The small size of our population did not allow the evaluation of the combined CMR protocol against myocardial biopsy. However, the positive LGE was the most common finding in all of our patients.
Concerning the diagnostic accuracy of the myocardial biopsy, the sampling error remains the most significant limitation. Although 4-6 biopsy samples are routinely performed during a diagnostic procedure, a careful postmortem analysis of proven myocarditis cases demonstrated that > 17 samples were necessary to correctly diagnose myocarditis in >80% of cases [36] . Because this number of biopsies is not feasible in clinical practice, the lack of sensitivity of biopsy is apparent. Additionally, it is an invasive technique and can not be used easily for follow-up. Furthermore, PCR gives evidence of pathologic genome in myocardium even without histological documentation of myocarditis [37] . However, PCR is a very sensitive technique which may lead in false positive results. These findings weaken the role of PCR and further emphasize the role of CMR in the detection of myocarditis [38] .
Limitations of the study: The small number of evaluated patients, the lack of targeted biopsy according to CMR findings and the lack of follow-up should be considered as the main limitations of the study. Additionally, the examined patients' population was selected because of cardiac symptoms and did not represent the true incidence of myocardial inflammation in these autoimmune diseases.
In conclusion, the presence of myocarditis (with or without LV dysfunction) in autoimmune diseases seems to have a multifactorial origin, being the result of interaction of different patho-physiologic processes such as vasculitis, circulating antibodies, abnormal immune response and/or infection and can be found even in adequately treated for the systemic disease patients. The diagnosis of myocardial inflammation should be confirmed by CMR, which is a noninvasive, reliable tool for the investigation of these patients.
